Substituting Doxorubicin with Nonpegylated Liposomal Doxorubicin for the Treatment of Early Breast Cancer: Results of a Retrospective Study

Introduction. Evidence from the metastatic setting suggests that replacing conventional doxorubicin with nonpegylated liposomal doxorubicin (NPLD) for early breast cancer may maintain efficacy whilst reducing long-term cardiotoxicity, an important consideration with many patients going on to receive...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Davidson, Neville, Camburn, Teresa, Keary, Ian, Houghton, David
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Hindawi Publishing Corporation 2014
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913086/
https://ncbi.nlm.nih.gov/pubmed/24527216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/984067
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items